Back to the article

HealthRX.com · Printable medication review sheet

After pancreatitis on Ozempic: choosing the next medicine

Take this to the visit where the next diabetes or weight medicine is chosen. It records how the episode was confirmed, how severe it was and whether a cause was found and fixed, the factors this page's decision framework weighs, and the choice you make together.

Companion to “Ozempic and Pancreatitis: Alternatives Without This Side Effect” · healthrx.com/side-effects-ozempic-pancreatitis/alternatives-without-this · Facts checked 2026-10-18

The episode

Date and where it was treated
How it was confirmedpain pattern, lipase level, CT or MRI findings
Severitymild, moderately severe, severe; any necrosis
Cause foundgallstones, triglycerides, alcohol, another medicine, none found
Gallbladder removed? Date
Date symptoms and labs were back to normal

What the decision framework on this page weighs

  • A clear cause that has been corrected, such as removed gallstones or treated triglycerides
  • No cause found after imaging, triglycerides and an alcohol history
  • A severe or necrotizing episode
  • Two or more episodes in my lifetime
  • Heavy drinking or very high triglycerides still present
  • Family history of pancreatic disease or cancer

Label wording and trial counts

  • Current Ozempic label: when pancreatitis is suspected, discontinue Ozempic and begin appropriate management.[1]
  • March 2022 Ozempic label: after confirmed pancreatitis, Ozempic should not be restarted, and other diabetes medicines should be considered for people with a history of pancreatitis.[2]
  • Ozempic glycemic-control trials: 7 adjudicated cases on Ozempic (0.3 per 100 patient-years) against 3 on comparators (0.2).[1]
  • Semaglutide tablet trials: 6 serious pancreatitis events (0.1 per 100 patient-years) against 1 on comparators.[3]
  • Gallstones were reported in 1.5% of patients on Ozempic 0.5 mg and 0.4% on 1 mg in placebo-controlled trials.[1]

To settle with your specialist

  1. Did my episode meet the formal criteria for acute pancreatitis, and how severe was it?
  2. Was a cause found, and has it been fully dealt with?
  3. Given that, is another GLP-1 medicine reasonable for me, or should I leave the class?
  4. How much weight or glucose benefit would I give up with a non-GLP-1 option?
  5. Should a pancreas specialist see me before we decide?

Decision recorded

Medicine chosen and starting dose
Reason for the choice
Symptoms that mean stop and call
Follow-up date
Sources for the facts on this sheet
  1. Novo Nordisk, via DailyMed. Ozempic (semaglutide) injection, for subcutaneous use: prescribing information and Medication Guide. Effective 2026-06-01. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  2. Novo Nordisk; archived by the U.S. Food and Drug Administration. Ozempic (semaglutide) injection, for subcutaneous use: prescribing information, revised 03/2022 (FDA label archive). Accessed 2026-10-18. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s009lbl.pdf
  3. Novo Nordisk, via DailyMed. Rybelsus (semaglutide) tablets and Ozempic (semaglutide) tablets, for oral use: prescribing information and Medication Guide. Effective 2026-01-30. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98

This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.